{"count":220489,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=83","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=81","results":[{"created":"2025-12-18T13:31:05.042776+11:00","panel_name":"Retinitis pigmentosa","panel_id":277,"panel_version":"0.226","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MT-TE as ready","entity_name":"MT-TE","entity_type":"gene"},{"created":"2025-12-18T13:31:05.032647+11:00","panel_name":"Retinitis pigmentosa","panel_id":277,"panel_version":"0.226","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mt-te has been classified as Green List (High Evidence).","entity_name":"MT-TE","entity_type":"gene"},{"created":"2025-12-18T13:30:50.599209+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"1.512","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MT-TE as ready","entity_name":"MT-TE","entity_type":"gene"},{"created":"2025-12-18T13:30:50.587675+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"1.512","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mt-te has been classified as Green List (High Evidence).","entity_name":"MT-TE","entity_type":"gene"},{"created":"2025-12-18T13:30:36.400737+11:00","panel_name":"Deafness_IsolatedAndComplex","panel_id":209,"panel_version":"1.305","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MT-TE as ready","entity_name":"MT-TE","entity_type":"gene"},{"created":"2025-12-18T13:30:36.384978+11:00","panel_name":"Deafness_IsolatedAndComplex","panel_id":209,"panel_version":"1.305","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mt-te has been classified as Green List (High Evidence).","entity_name":"MT-TE","entity_type":"gene"},{"created":"2025-12-18T13:30:24.627626+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"1.311","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MT-TE as ready","entity_name":"MT-TE","entity_type":"gene"},{"created":"2025-12-18T13:30:24.618084+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"1.311","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mt-te has been classified as Green List (High Evidence).","entity_name":"MT-TE","entity_type":"gene"},{"created":"2025-12-18T13:30:13.669782+11:00","panel_name":"Ataxia","panel_id":271,"panel_version":"1.163","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MT-TE as ready","entity_name":"MT-TE","entity_type":"gene"},{"created":"2025-12-18T13:30:13.660252+11:00","panel_name":"Ataxia","panel_id":271,"panel_version":"1.163","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mt-te has been classified as Green List (High Evidence).","entity_name":"MT-TE","entity_type":"gene"},{"created":"2025-12-18T13:30:07.687872+11:00","panel_name":"Cardiomyopathy_Paediatric","panel_id":3270,"panel_version":"0.209","user_name":"Zornitza Stark","item_type":"panel","text":"Copied gene MT-TG from panel Mitochondrial disease","entity_name":null,"entity_type":null},{"created":"2025-12-18T13:30:07.592733+11:00","panel_name":"Cardiomyopathy_Paediatric","panel_id":3270,"panel_version":"0.209","user_name":"Zornitza Stark","item_type":"entity","text":"gene: MT-TG was added\ngene: MT-TG was added to Cardiomyopathy_Paediatric. Sources: Expert Review Green,Expert list\nmtDNA tags were added to gene: MT-TG.\nMode of inheritance for gene gene: MT-TG was set to MITOCHONDRIAL\nPublications for gene: MT-TG were set to 8079988; 9199564; 11971101; 16120360; 32337339; 35432167; 10090480\nPhenotypes for gene: MT-TG were set to Mitochondrial disease (MONDO:0044970), MT-TG-related","entity_name":"MT-TG","entity_type":"gene"},{"created":"2025-12-18T13:30:05.953688+11:00","panel_name":"Ataxia","panel_id":271,"panel_version":"1.164","user_name":"Zornitza Stark","item_type":"panel","text":"Copied gene MT-TG from panel Mitochondrial disease","entity_name":null,"entity_type":null},{"created":"2025-12-18T13:30:05.274579+11:00","panel_name":"Ataxia","panel_id":271,"panel_version":"1.164","user_name":"Zornitza Stark","item_type":"entity","text":"gene: MT-TG was added\ngene: MT-TG was added to Ataxia. Sources: Expert Review Green,Expert list\nmtDNA tags were added to gene: MT-TG.\nMode of inheritance for gene gene: MT-TG was set to MITOCHONDRIAL\nPublications for gene: MT-TG were set to 8079988; 9199564; 11971101; 16120360; 32337339; 35432167; 10090480\nPhenotypes for gene: MT-TG were set to Mitochondrial disease (MONDO:0044970), MT-TG-related","entity_name":"MT-TG","entity_type":"gene"},{"created":"2025-12-18T13:30:00.914372+11:00","panel_name":"Rhabdomyolysis and Metabolic Myopathy","panel_id":3084,"panel_version":"1.35","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MT-TD as ready","entity_name":"MT-TD","entity_type":"gene"},{"created":"2025-12-18T13:30:00.901083+11:00","panel_name":"Rhabdomyolysis and Metabolic Myopathy","panel_id":3084,"panel_version":"1.35","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mt-td has been classified as Green List (High Evidence).","entity_name":"MT-TD","entity_type":"gene"},{"created":"2025-12-18T13:29:05.401401+11:00","panel_name":"Stroke","panel_id":3141,"panel_version":"1.39","user_name":"Zornitza Stark","item_type":"panel","text":"Copied gene MT-TE from panel Mitochondrial disease","entity_name":null,"entity_type":null},{"created":"2025-12-18T13:29:05.303253+11:00","panel_name":"Stroke","panel_id":3141,"panel_version":"1.39","user_name":"Zornitza Stark","item_type":"entity","text":"gene: MT-TE was added\ngene: MT-TE was added to Stroke. Sources: Expert Review Green,Expert list\nmtDNA tags were added to gene: MT-TE.\nMode of inheritance for gene gene: MT-TE was set to MITOCHONDRIAL\nPublications for gene: MT-TE were set to 8155739; 21194154; 17715279; 23334599; 7726155; 7726154; 9353617; 15048886; 15670724; 23847141; 23334599; 17266923; 17056256\nPhenotypes for gene: MT-TE were set to Mitochondrial disease (MONDO:0044970), MT-TE-related","entity_name":"MT-TE","entity_type":"gene"},{"created":"2025-12-18T13:29:04.964536+11:00","panel_name":"Rhabdomyolysis and Metabolic Myopathy","panel_id":3084,"panel_version":"1.35","user_name":"Zornitza Stark","item_type":"panel","text":"Copied gene MT-TE from panel Mitochondrial disease","entity_name":null,"entity_type":null},{"created":"2025-12-18T13:29:04.799993+11:00","panel_name":"Rhabdomyolysis and Metabolic Myopathy","panel_id":3084,"panel_version":"1.35","user_name":"Zornitza Stark","item_type":"entity","text":"gene: MT-TE was added\ngene: MT-TE was added to Rhabdomyolysis and Metabolic Myopathy. Sources: Expert Review Green,Expert list\nmtDNA tags were added to gene: MT-TE.\nMode of inheritance for gene gene: MT-TE was set to MITOCHONDRIAL\nPublications for gene: MT-TE were set to 8155739; 21194154; 17715279; 23334599; 7726155; 7726154; 9353617; 15048886; 15670724; 23847141; 23334599; 17266923; 17056256\nPhenotypes for gene: MT-TE were set to Mitochondrial disease (MONDO:0044970), MT-TE-related","entity_name":"MT-TE","entity_type":"gene"},{"created":"2025-12-18T13:28:46.022223+11:00","panel_name":"Retinitis pigmentosa","panel_id":277,"panel_version":"0.226","user_name":"Zornitza Stark","item_type":"panel","text":"Copied gene MT-TE from panel Mitochondrial disease","entity_name":null,"entity_type":null},{"created":"2025-12-18T13:28:45.889265+11:00","panel_name":"Retinitis pigmentosa","panel_id":277,"panel_version":"0.226","user_name":"Zornitza Stark","item_type":"entity","text":"gene: MT-TE was added\ngene: MT-TE was added to Retinitis pigmentosa. Sources: Expert Review Green,Expert list\nmtDNA tags were added to gene: MT-TE.\nMode of inheritance for gene gene: MT-TE was set to MITOCHONDRIAL\nPublications for gene: MT-TE were set to 8155739; 21194154; 17715279; 23334599; 7726155; 7726154; 9353617; 15048886; 15670724; 23847141; 23334599; 17266923; 17056256\nPhenotypes for gene: MT-TE were set to Mitochondrial disease (MONDO:0044970), MT-TE-related","entity_name":"MT-TE","entity_type":"gene"},{"created":"2025-12-18T13:28:43.648374+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"1.512","user_name":"Zornitza Stark","item_type":"panel","text":"Copied gene MT-TE from panel Mitochondrial disease","entity_name":null,"entity_type":null},{"created":"2025-12-18T13:28:43.270854+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"1.512","user_name":"Zornitza Stark","item_type":"entity","text":"gene: MT-TE was added\ngene: MT-TE was added to Intellectual disability syndromic and non-syndromic. Sources: Expert Review Green,Expert list\nmtDNA tags were added to gene: MT-TE.\nMode of inheritance for gene gene: MT-TE was set to MITOCHONDRIAL\nPublications for gene: MT-TE were set to 8155739; 21194154; 17715279; 23334599; 7726155; 7726154; 9353617; 15048886; 15670724; 23847141; 23334599; 17266923; 17056256\nPhenotypes for gene: MT-TE were set to Mitochondrial disease (MONDO:0044970), MT-TE-related","entity_name":"MT-TE","entity_type":"gene"},{"created":"2025-12-18T13:28:00.686540+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"1.311","user_name":"Zornitza Stark","item_type":"panel","text":"Copied gene MT-TE from panel Mitochondrial disease","entity_name":null,"entity_type":null},{"created":"2025-12-18T13:28:00.417445+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"1.311","user_name":"Zornitza Stark","item_type":"entity","text":"gene: MT-TE was added\ngene: MT-TE was added to Genetic Epilepsy. Sources: Expert Review Green,Expert list\nmtDNA tags were added to gene: MT-TE.\nMode of inheritance for gene gene: MT-TE was set to MITOCHONDRIAL\nPublications for gene: MT-TE were set to 8155739; 21194154; 17715279; 23334599; 7726155; 7726154; 9353617; 15048886; 15670724; 23847141; 23334599; 17266923; 17056256\nPhenotypes for gene: MT-TE were set to Mitochondrial disease (MONDO:0044970), MT-TE-related","entity_name":"MT-TE","entity_type":"gene"},{"created":"2025-12-18T13:27:06.391009+11:00","panel_name":"Deafness_IsolatedAndComplex","panel_id":209,"panel_version":"1.305","user_name":"Zornitza Stark","item_type":"panel","text":"Copied gene MT-TE from panel Mitochondrial disease","entity_name":null,"entity_type":null},{"created":"2025-12-18T13:27:06.167421+11:00","panel_name":"Deafness_IsolatedAndComplex","panel_id":209,"panel_version":"1.305","user_name":"Zornitza Stark","item_type":"entity","text":"gene: MT-TE was added\ngene: MT-TE was added to Deafness_IsolatedAndComplex. Sources: Expert Review Green,Expert list\nmtDNA tags were added to gene: MT-TE.\nMode of inheritance for gene gene: MT-TE was set to MITOCHONDRIAL\nPublications for gene: MT-TE were set to 8155739; 21194154; 17715279; 23334599; 7726155; 7726154; 9353617; 15048886; 15670724; 23847141; 23334599; 17266923; 17056256\nPhenotypes for gene: MT-TE were set to Mitochondrial disease (MONDO:0044970), MT-TE-related","entity_name":"MT-TE","entity_type":"gene"},{"created":"2025-12-18T13:26:29.085494+11:00","panel_name":"Ataxia","panel_id":271,"panel_version":"1.163","user_name":"Zornitza Stark","item_type":"panel","text":"Copied gene MT-TE from panel Mitochondrial disease","entity_name":null,"entity_type":null},{"created":"2025-12-18T13:26:28.923330+11:00","panel_name":"Ataxia","panel_id":271,"panel_version":"1.163","user_name":"Zornitza Stark","item_type":"entity","text":"gene: MT-TE was added\ngene: MT-TE was added to Ataxia. Sources: Expert Review Green,Expert list\nmtDNA tags were added to gene: MT-TE.\nMode of inheritance for gene gene: MT-TE was set to MITOCHONDRIAL\nPublications for gene: MT-TE were set to 8155739; 21194154; 17715279; 23334599; 7726155; 7726154; 9353617; 15048886; 15670724; 23847141; 23334599; 17266923; 17056256\nPhenotypes for gene: MT-TE were set to Mitochondrial disease (MONDO:0044970), MT-TE-related","entity_name":"MT-TE","entity_type":"gene"},{"created":"2025-12-18T13:25:14.393155+11:00","panel_name":"Rhabdomyolysis and Metabolic Myopathy","panel_id":3084,"panel_version":"1.34","user_name":"Zornitza Stark","item_type":"panel","text":"Copied gene MT-TD from panel Mitochondrial disease","entity_name":null,"entity_type":null},{"created":"2025-12-18T13:25:14.244439+11:00","panel_name":"Rhabdomyolysis and Metabolic Myopathy","panel_id":3084,"panel_version":"1.34","user_name":"Zornitza Stark","item_type":"entity","text":"gene: MT-TD was added\ngene: MT-TD was added to Rhabdomyolysis and Metabolic Myopathy. Sources: Expert Review Green,Expert list\nmtDNA tags were added to gene: MT-TD.\nMode of inheritance for gene gene: MT-TD was set to MITOCHONDRIAL\nPublications for gene: MT-TD were set to 9811342; 10488907; 16059939; 18676632; 23696415; 25447692; 27536005; 30030363; 3054486; 19535463\nPhenotypes for gene: MT-TD were set to Mitochondrial disease (MONDO:0044970), MT-TD-related","entity_name":"MT-TD","entity_type":"gene"},{"created":"2025-12-18T13:24:44.934004+11:00","panel_name":"Mitochondrial disease","panel_id":203,"panel_version":"1.0","user_name":"Zornitza Stark","item_type":"entity","text":"commented on gene: MT-TD: Predominantly reported with mitochondrial myopathy.","entity_name":"MT-TD","entity_type":"gene"},{"created":"2025-12-18T09:54:58.430192+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"1.483","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: EMX2 as Red List (low evidence)","entity_name":"EMX2","entity_type":"gene"},{"created":"2025-12-18T09:54:58.421899+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"1.483","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: emx2 has been classified as Red List (Low Evidence).","entity_name":"EMX2","entity_type":"gene"},{"created":"2025-12-18T09:54:17.107705+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"1.482","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: EMX2: Changed rating: RED","entity_name":"EMX2","entity_type":"gene"},{"created":"2025-12-18T09:53:34.733200+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"1.511","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: EMX2 as Red List (low evidence)","entity_name":"EMX2","entity_type":"gene"},{"created":"2025-12-18T09:53:34.724949+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"1.511","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: emx2 has been classified as Red List (Low Evidence).","entity_name":"EMX2","entity_type":"gene"},{"created":"2025-12-18T09:52:35.400698+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"1.510","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: EMX2: Changed rating: RED","entity_name":"EMX2","entity_type":"gene"},{"created":"2025-12-18T09:52:11.487266+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"1.310","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: EMX2 as Red List (low evidence)","entity_name":"EMX2","entity_type":"gene"},{"created":"2025-12-18T09:52:11.475812+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"1.310","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: emx2 has been classified as Red List (Low Evidence).","entity_name":"EMX2","entity_type":"gene"},{"created":"2025-12-18T09:51:22.074701+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"1.309","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: EMX2: Changed rating: RED","entity_name":"EMX2","entity_type":"gene"},{"created":"2025-12-18T09:51:04.163860+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.3804","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: EMX2: Changed rating: RED","entity_name":"EMX2","entity_type":"gene"},{"created":"2025-12-18T09:50:40.340253+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.3804","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: EMX2 as Red List (low evidence)","entity_name":"EMX2","entity_type":"gene"},{"created":"2025-12-18T09:50:40.330059+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.3804","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: emx2 has been classified as Red List (Low Evidence).","entity_name":"EMX2","entity_type":"gene"},{"created":"2025-12-18T09:50:03.765172+11:00","panel_name":"Polymicrogyria and Schizencephaly","panel_id":18,"panel_version":"0.204","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: EMX2 as Red List (low evidence)","entity_name":"EMX2","entity_type":"gene"},{"created":"2025-12-18T09:50:03.754593+11:00","panel_name":"Polymicrogyria and Schizencephaly","panel_id":18,"panel_version":"0.204","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: emx2 has been classified as Red List (Low Evidence).","entity_name":"EMX2","entity_type":"gene"},{"created":"2025-12-18T08:08:21.410706+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"1.510","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CRNKL1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Microcephaly, progressive, with simplified gyral pattern and cerebellar hypoplasia, MIM# 621436; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CRNKL1","entity_type":"gene"},{"created":"2025-12-18T08:07:55.882393+11:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"1.377","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CRNKL1 were changed from complex neurodevelopmental disorder MONDO:0100038 CRNKL1-related to Microcephaly, progressive, with simplified gyral pattern and cerebellar hypoplasia, MIM# 621436","entity_name":"CRNKL1","entity_type":"gene"},{"created":"2025-12-18T08:07:24.749916+11:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"1.376","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CRNKL1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Microcephaly, progressive, with simplified gyral pattern and cerebellar hypoplasia, MIM# 621436; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CRNKL1","entity_type":"gene"},{"created":"2025-12-18T08:07:01.744980+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.3803","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CRNKL1 were changed from complex neurodevelopmental disorder MONDO:0100038 to Microcephaly, progressive, with simplified gyral pattern and cerebellar hypoplasia, MIM# 621436","entity_name":"CRNKL1","entity_type":"gene"},{"created":"2025-12-18T08:06:43.196762+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.3802","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CRNKL1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Microcephaly, progressive, with simplified gyral pattern and cerebellar hypoplasia, MIM# 621436; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CRNKL1","entity_type":"gene"},{"created":"2025-12-18T08:06:24.610655+11:00","panel_name":"Cerebellar and Pontocerebellar Hypoplasia","panel_id":72,"panel_version":"1.93","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CRNKL1 were changed from complex neurodevelopmental disorder MONDO:0100038 to Microcephaly, progressive, with simplified gyral pattern and cerebellar hypoplasia, MIM# 621436","entity_name":"CRNKL1","entity_type":"gene"},{"created":"2025-12-18T08:05:56.855255+11:00","panel_name":"Cerebellar and Pontocerebellar Hypoplasia","panel_id":72,"panel_version":"1.92","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CRNKL1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Microcephaly, progressive, with simplified gyral pattern and cerebellar hypoplasia, MIM# 621436; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CRNKL1","entity_type":"gene"},{"created":"2025-12-18T08:05:39.191897+11:00","panel_name":"Polymicrogyria and Schizencephaly","panel_id":18,"panel_version":"0.203","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CRNKL1 were changed from Complex neurodevelopmental disorder, CRNKL1-related - MONDO:0100038 to Microcephaly, progressive, with simplified gyral pattern and cerebellar hypoplasia, MIM# 621436","entity_name":"CRNKL1","entity_type":"gene"},{"created":"2025-12-18T08:05:04.679559+11:00","panel_name":"Polymicrogyria and Schizencephaly","panel_id":18,"panel_version":"0.202","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CRNKL1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Microcephaly, progressive, with simplified gyral pattern and cerebellar hypoplasia, MIM# 621436; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CRNKL1","entity_type":"gene"},{"created":"2025-12-17T18:39:17.741891+11:00","panel_name":"Mitochondrial disease","panel_id":203,"panel_version":"1.0","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TPK1 as ready","entity_name":"TPK1","entity_type":"gene"},{"created":"2025-12-17T18:39:17.731421+11:00","panel_name":"Mitochondrial disease","panel_id":203,"panel_version":"1.0","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tpk1 has been classified as Green List (High Evidence).","entity_name":"TPK1","entity_type":"gene"},{"created":"2025-12-17T17:32:23.873170+11:00","panel_name":"Additional findings_Paediatric","panel_id":3302,"panel_version":"0.279","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SNTA1 as ready","entity_name":"SNTA1","entity_type":"gene"},{"created":"2025-12-17T17:32:23.865331+11:00","panel_name":"Additional findings_Paediatric","panel_id":3302,"panel_version":"0.279","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: snta1 has been classified as Red List (Low Evidence).","entity_name":"SNTA1","entity_type":"gene"},{"created":"2025-12-17T17:32:19.400791+11:00","panel_name":"Additional findings_Paediatric","panel_id":3302,"panel_version":"0.279","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: SNTA1 as Red List (low evidence)","entity_name":"SNTA1","entity_type":"gene"},{"created":"2025-12-17T17:32:19.389657+11:00","panel_name":"Additional findings_Paediatric","panel_id":3302,"panel_version":"0.279","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: snta1 has been classified as Red List (Low Evidence).","entity_name":"SNTA1","entity_type":"gene"},{"created":"2025-12-17T17:32:00.468379+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.147","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SNTA1 as ready","entity_name":"SNTA1","entity_type":"gene"},{"created":"2025-12-17T17:32:00.450775+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.147","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: snta1 has been classified as Red List (Low Evidence).","entity_name":"SNTA1","entity_type":"gene"},{"created":"2025-12-17T17:31:55.642538+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.147","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: SNTA1 were changed from Long QT syndrome to Long QT syndrome 12 MIM#612955","entity_name":"SNTA1","entity_type":"gene"},{"created":"2025-12-17T17:31:26.317033+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.146","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: SNTA1 as Red List (low evidence)","entity_name":"SNTA1","entity_type":"gene"},{"created":"2025-12-17T17:31:26.306451+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.146","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: snta1 has been classified as Red List (Low Evidence).","entity_name":"SNTA1","entity_type":"gene"},{"created":"2025-12-17T17:31:18.086643+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.145","user_name":"Zornitza Stark","item_type":"entity","text":"Tag disputed tag was added to gene: SNTA1.","entity_name":"SNTA1","entity_type":"gene"},{"created":"2025-12-17T17:31:09.606626+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.145","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: SNTA1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Long QT syndrome 12 MIM#612955; Mode of inheritance: None","entity_name":"SNTA1","entity_type":"gene"},{"created":"2025-12-17T17:28:58.843017+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.145","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SDHAF2 as ready","entity_name":"SDHAF2","entity_type":"gene"},{"created":"2025-12-17T17:28:58.833082+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.145","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: sdhaf2 has been classified as Amber List (Moderate Evidence).","entity_name":"SDHAF2","entity_type":"gene"},{"created":"2025-12-17T17:28:55.968199+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.145","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: SDHAF2 were changed from Hereditary Paraganglioma-Pheochromocytoma Syndromes to Paragangliomas 2, MIM# 601650","entity_name":"SDHAF2","entity_type":"gene"},{"created":"2025-12-17T17:28:42.002437+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.144","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: SDHAF2: Rating: AMBER; Mode of pathogenicity: None; Publications: ; Phenotypes: Paragangliomas 2, MIM# 601650; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"SDHAF2","entity_type":"gene"},{"created":"2025-12-17T17:26:12.182919+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.144","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: RBM20 as ready","entity_name":"RBM20","entity_type":"gene"},{"created":"2025-12-17T17:26:12.172480+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.144","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rbm20 has been classified as Amber List (Moderate Evidence).","entity_name":"RBM20","entity_type":"gene"},{"created":"2025-12-17T17:26:06.822403+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.144","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: RBM20 were changed from Cardiomyopathy, dilated, 1DD to Cardiomyopathy, dilated, 1DD, MIM# 613172 AD","entity_name":"RBM20","entity_type":"gene"},{"created":"2025-12-17T17:25:53.303815+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.143","user_name":"Zornitza Stark","item_type":"entity","text":"changed review comment from: DEFINITIVE association with DCM. Not assessed for actionability by ClinGen yet.; to: DEFINITIVE association with DCM. Not assessed for actionability by ClinGen yet. Not suitable for gNBS.","entity_name":"RBM20","entity_type":"gene"},{"created":"2025-12-17T17:25:44.658131+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.143","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: RBM20: Rating: AMBER; Mode of pathogenicity: None; Publications: ; Phenotypes: Cardiomyopathy, dilated, 1DD, MIM# 613172 AD; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"RBM20","entity_type":"gene"},{"created":"2025-12-17T17:21:34.911244+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.143","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MYLK as ready","entity_name":"MYLK","entity_type":"gene"},{"created":"2025-12-17T17:21:34.901161+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.143","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mylk has been classified as Amber List (Moderate Evidence).","entity_name":"MYLK","entity_type":"gene"},{"created":"2025-12-17T17:21:30.553439+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.143","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MYLK were changed from Aortic aneurysm, familial thoracic 7 to Aortic aneurysm, familial thoracic 7, MIM#613780","entity_name":"MYLK","entity_type":"gene"},{"created":"2025-12-17T17:21:17.715552+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.142","user_name":"Zornitza Stark","item_type":"entity","text":"changed review comment from: STRONG by ClinGen in terms of gene-disease relationship but not assessed for actionability yet.; to: STRONG by ClinGen in terms of gene-disease relationship but not assessed for actionability yet. Not suitable for gNBS.","entity_name":"MYLK","entity_type":"gene"},{"created":"2025-12-17T17:21:05.395426+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.142","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MYLK: Rating: AMBER; Mode of pathogenicity: None; Publications: ; Phenotypes: Aortic aneurysm, familial thoracic 7, MIM#613780; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"MYLK","entity_type":"gene"},{"created":"2025-12-17T17:19:45.017248+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.142","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MYL3 as ready","entity_name":"MYL3","entity_type":"gene"},{"created":"2025-12-17T17:19:45.000750+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.142","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: myl3 has been classified as Amber List (Moderate Evidence).","entity_name":"MYL3","entity_type":"gene"},{"created":"2025-12-17T17:19:42.111837+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.142","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MYL3 were changed from Cardiomyopathy, familial hypertrophic, 8 to Cardiomyopathy, hypertrophic, 8, MIM# 608751","entity_name":"MYL3","entity_type":"gene"},{"created":"2025-12-17T17:18:34.410327+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.141","user_name":"Zornitza Stark","item_type":"entity","text":"changed review comment from: Not assessed by ClinGen Paed Actionability Group yet.; to: DEFINITIVE association with HCM. Not assessed by ClinGen Paed Actionability Group yet. Not suitable for gNBS.","entity_name":"MYL3","entity_type":"gene"},{"created":"2025-12-17T17:17:58.569760+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.141","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: MYL3: Changed phenotypes: Cardiomyopathy, hypertrophic, 8, MIM# 608751; Changed mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"MYL3","entity_type":"gene"},{"created":"2025-12-17T17:17:26.769432+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.141","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: MYL3: Changed rating: AMBER","entity_name":"MYL3","entity_type":"gene"},{"created":"2025-12-17T17:17:20.153713+11:00","panel_name":"Genomic newborn screening: BabyScreen+","panel_id":3931,"panel_version":"1.141","user_name":"Zornitza Stark","item_type":"entity","text":"commented on gene: MYL3","entity_name":"MYL3","entity_type":"gene"},{"created":"2025-12-17T16:57:06.646567+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"1.510","user_name":"Zornitza Stark","item_type":"entity","text":"Marked Region: ISCA-37421-Loss as ready","entity_name":"ISCA-37421-Loss","entity_type":"region"},{"created":"2025-12-17T16:57:06.640024+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"1.510","user_name":"Zornitza Stark","item_type":"entity","text":"Region: isca-37421-loss has been classified as Green List (High Evidence).","entity_name":"ISCA-37421-Loss","entity_type":"region"},{"created":"2025-12-17T16:56:46.168352+11:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.295","user_name":"Zornitza Stark","item_type":"entity","text":"Marked Region: ISCA-37423-Gain as ready","entity_name":"ISCA-37423-Gain","entity_type":"region"},{"created":"2025-12-17T16:56:46.161971+11:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.295","user_name":"Zornitza Stark","item_type":"entity","text":"Region: isca-37423-gain has been classified as Green List (High Evidence).","entity_name":"ISCA-37423-Gain","entity_type":"region"},{"created":"2025-12-17T16:56:40.499228+11:00","panel_name":"Clefting disorders","panel_id":3368,"panel_version":"0.295","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for Region: ISCA-37423-Gain were set to 26097203; 25520754","entity_name":"ISCA-37423-Gain","entity_type":"region"},{"created":"2025-12-17T16:55:34.973303+11:00","panel_name":"Congenital Heart Defect","panel_id":76,"panel_version":"0.512","user_name":"Zornitza Stark","item_type":"entity","text":"Marked Region: ISCA-37423-Gain as ready","entity_name":"ISCA-37423-Gain","entity_type":"region"},{"created":"2025-12-17T16:55:34.962112+11:00","panel_name":"Congenital Heart Defect","panel_id":76,"panel_version":"0.512","user_name":"Zornitza Stark","item_type":"entity","text":"Region: isca-37423-gain has been classified as Green List (High Evidence).","entity_name":"ISCA-37423-Gain","entity_type":"region"},{"created":"2025-12-17T16:55:15.997009+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"1.510","user_name":"Zornitza Stark","item_type":"entity","text":"Marked Region: ISCA-37423-Gain as ready","entity_name":"ISCA-37423-Gain","entity_type":"region"},{"created":"2025-12-17T16:55:15.987563+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"1.510","user_name":"Zornitza Stark","item_type":"entity","text":"Region: isca-37423-gain has been classified as Green List (High Evidence).","entity_name":"ISCA-37423-Gain","entity_type":"region"},{"created":"2025-12-17T16:50:45.311423+11:00","panel_name":"Mitochondrial disease","panel_id":203,"panel_version":"1.0","user_name":"Zornitza Stark","item_type":"panel","text":"promoted panel to version 1.0","entity_name":null,"entity_type":null}]}